Top Medical News

Children Exposed to Maternal Cancer Show Normal Cognitive and Behavioral Outcomes

January 24th 2023

An analysis of 141 children who had prenatal exposure to maternal cancer showed promising cognitive and behavioral functions at age 9 years.

Retrospective MOUNTAINEER Analysis Sheds Light on Optimal HER2 Testing Practices in mCRC

January 23rd 2023

Both the gastric and breast cancer HER2 scoring algorithms may be useful in determining which patients with metastatic colorectal cancer may derive benefit with tucatinib/ trastuzumab.

Nurses Must Stay Up-to-Date With Treatments and Clinical Trials for Patients With Cervical Cancer

January 23rd 2023

January is cervical cancer awareness month. This third article in a series highlights current cervical cancer treatment options.

Zolbetuximab Plus mFOLFOX6 Extends Survival for Patients with CLDN18.2+ Advanced Gastric/GEJ Adenocarcinoma

January 22nd 2023

For patients with CLDN18.2-positive, HER2-negative locally advanced unresectable or metastatic gastric/gastroesophageal junction adenocarcinoma, treatment with zolbetuximab/mFOLFOX6 yielded a progression-free survival (PFS) of 10.61 months whereas placebo/mFOLFOX6 resulted in a PFS of 8.67 months.

Firstline Nivolumab/Chemotherapy Continues To Outperform Chemotherapy Alone for Advanced Gastric/GEJ/Esophageal Cancer At 3-Year Follow-Up

January 21st 2023

In an all-randomized population of patients with advanced gastric cancer, gastroesophageal junction, or esophageal adenocarcinoma, adding nivolumab to chemotherapy yielded a 21% reduction in the risk of death.

Most Recent